clevidipine - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
CLEVIPREX clevidipine, 25 mg in 50 mL injectable emulsion, Single Use Vials
AUST R: 203313
Active ingredients:
clevidipine

Dosage form:
Injection, emulsion

Sponsor:
Chiesi Australia Pty Ltd

Phone:
1800943587

From
01 Mar 2026
to
31 May 2026

Shortage status:
Anticipated

Availability:
Available

Reason:
Transport / Logistic issues / Storage capacity issues

Management action:
The TGA is currently investigating management actions. Alternative unapproved products may be available under the Special Access Scheme.